🇸🇬 Huluc63 in Singapore

Huluc63 (elotuzumab) regulatory status in Singapore.

Marketing authorisation

HSA

  • Status: likely_approved

Huluc63 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Singapore

Frequently asked questions

Is Huluc63 approved in Singapore?

Yes. HSA has authorised it.

Who is the marketing authorisation holder for Huluc63 in Singapore?

Bristol-Myers Squibb is the originator. The local marketing authorisation holder may differ — check the official source linked above.